phenylmethylsulfonyl fluoride has been researched along with 1,2-dipalmitoylphosphatidylcholine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chapman, MJ; Dentan, C; Ninio, E; Tselepis, AD | 1 |
| Inchley, K; Lewis, JF; Maitra, G; Novick, RJ; Possmayer, F; Veldhuizen, RA | 1 |
2 other study(ies) available for phenylmethylsulfonyl fluoride and 1,2-dipalmitoylphosphatidylcholine
| Article | Year |
|---|---|
Pefabloc, 4-[2-aminoethyl]benzenesulfonyl fluoride, is a new, potent nontoxic and irreversible inhibitor of PAF-degrading acetylhydrolase.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; 1,2-Dipalmitoylphosphatidylcholine; Animals; Brain; Dose-Response Relationship, Drug; Enzymes; Humans; Lipoproteins; Monocytes; Phenylmethylsulfonyl Fluoride; Phospholipases A; Phospholipases A2; Platelet Activating Factor; Rats; Sulfones; Trypsin Inhibitors | 1996 |
Acute lung injury and lung transplantation influence in vitro subtype conversion of pulmonary surfactant.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Acute Disease; Animals; Dogs; Enzyme Inhibitors; Hyperventilation; Ischemia; Lipids; Lung Diseases; Lung Transplantation; Phenylmethylsulfonyl Fluoride; Protein Isoforms; Pulmonary Circulation; Pulmonary Surfactants; Reference Values | 2002 |